TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
14.17
+1.95 (15.96%)
Oct 8, 2025, 12:03 PM EDT - Market open
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $11.81 million as of October 8, 2025. Its market cap has increased by 94.88% in one year.
Market Cap
11.81M
Enterprise Value
2.81M
1-Year Change
94.88%
Ranking
Category
Stock Price
$14.17
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $11.81M, a decrease of -75.32%. That is a compound annual growth rate of -28.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 10.19M | 334.19% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 766.26B |
| Johnson & Johnson | 454.28B |
| AbbVie | 407.00B |
| UnitedHealth Group | 334.53B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.62B |